Home/Filings/4/0001033905-20-000096
4//SEC Filing

Collins Charles J. 4

Accession 0001033905-20-000096

CIK 0001033905other

Filed

Jul 16, 8:00 PM ET

Accepted

Jul 17, 10:52 AM ET

Size

8.4 KB

Accession

0001033905-20-000096

Insider Transaction Report

Form 4
Period: 2020-07-15
Collins Charles J.
SR VP, R&D - US
Transactions
  • Sale

    Common Stock

    2020-07-15$34.50/sh37,252$1,285,29834,554 total
  • Exercise/Conversion

    Common Stock

    2020-07-15$15.93/sh+37,252$593,42471,462 total
  • Exercise/Conversion

    Stock Option (Right To Buy)

    2020-07-15$15.93/sh37,252$593,4240 total
    Exercise: $15.93From: 2017-03-11Exp: 2022-03-11Common Stock (37,252 underlying)
Footnotes (2)
  • [F1]This sale is being made pursuant to a trading plan intended to comply with Rule 10b5-1 adopted by the seller on May 28, 2020. The representation regarding the seller's knowledge of material adverse non-public information speaks as of the date that the aforementioned trading plan was adopted.
  • [F2]This balance includes 344 shares obtained under the Luminex Corporation Employee Stock Purchase Plan on May 29, 2020.

Issuer

LUMINEX CORP

CIK 0001033905

Entity typeother

Related Parties

1
  • filerCIK 0001732500

Filing Metadata

Form type
4
Filed
Jul 16, 8:00 PM ET
Accepted
Jul 17, 10:52 AM ET
Size
8.4 KB